Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19
Himanshu G. Toor, Devjani Banerjee, Soumya Lipsa Rath, Siddhi Darji
Topics & Concepts
FavipiravirRaltegravirComputational biologyIn silicoStavudineDrug developmentDrugSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug discoveryPharmacologyBiologyDrug repositioningDocking (animal)Coronavirus disease 2019 (COVID-19)VirologyBioinformaticsViral loadHuman immunodeficiency virus (HIV)MedicineInfectious disease (medical specialty)GeneticsAntiretroviral therapyDiseaseGenePathologyNursingComputational Drug Discovery Methodsvaccines and immunoinformatics approachesSARS-CoV-2 and COVID-19 Research